How Novel veterinary clinic tries to lower bills and empower employees

Novel, a Burlington veterinary clinic founded by Brendon Laing and Emma Harris, says its membership model and higher use of veterinary technicians helped it become cash-flow positive by month four. Memberships cost $24 per month for one pet or $30 for more, with 20%+ discounts and no exam fees; the clinic also pays vet techs about $100,000 annually, roughly twice the provincial average. Management is now developing a second location in Ancaster, Ont., and expanding a model aimed at lowering pet-care costs.

Analysis

This is less a pet-care story than a blueprint for services disintermediation: bundling membership pricing with delegated labor attacks the two biggest friction points in healthcare-like retail — price opacity and expensive practitioner time. If the model scales, the first-order winners are clinics that can standardize triage and reallocate veterinarians to high-acuity work; the second-order losers are legacy independent clinics that rely on exam-fee economics and underutilized DVM capacity.

The more important signal is labor-market leverage. Paying premium wages to vet techs while keeping cash flow positive implies the margin pool is not being destroyed; it is being reallocated from scarce, high-cost labor to a more abundant, lower-cost tier. That should force incumbents to either raise tech wages, compress DVM utilization, or accept share loss to a format that feels more like consumer healthcare retail than traditional animal medicine.

The adoption curve is the key risk. Membership economics work best when pet owners have repeat utilization, so this model is inherently stronger for chronic-care, older, or multi-pet households and weaker for low-touch customers. The real catalyst over the next 12–24 months is whether the second location proves the unit economics are portable; if expansion fails, this becomes a niche premium brand rather than a category shift. A broader macro risk is that any loosening in household budgets or a competitor with deeper capital could copy the pricing wrapper without matching service quality, eroding differentiation.

The contrarian view is that the market may be underestimating how sticky the incumbent system is: veterinary supply is local, trust-based, and heavily regulated, which slows national scaling and makes unit economics look better than network economics. Novel’s advantage may not be the membership itself, but the operational discipline around triage, which is much harder to clone than a discount plan. If that’s right, the best investment angle is not betting on a branded clinic chain immediately, but on the broader enablement layer — software, staffing, and specialty service providers that benefit from more efficient care delivery.

Key Decisions for Investors

• No direct public-equity trade available; use this as a thematic read-through for healthcare labor efficiency. Over the next 6-12 months, monitor public veterinary consolidators and pet-health platforms for evidence of membership or technician-led care adoption.
• Long consumer-facing pet-care enablers on weakness: PETS or WOOF only if management commentary starts highlighting lower visit friction and higher treatment compliance; otherwise stay flat given execution risk.
• Pair trade framework: long a healthcare-services operator with strong labor productivity vs short a legacy fee-for-service outpatient model if a public comp emerges showing similar labor arbitrage. The spread should work over 6-18 months if tech utilization trends replicate.
• Watch for any private-markets or VC follow-on into veterinary clinic rollups with delegated-care models. If capital floods in, expect a 12-24 month margin compression phase as the moat shifts from concept to execution.
• No options trade today; wait for a public comp announcing membership pricing or technician-led workflow before expressing the thesis. The edge here is in picking the second-order beneficiaries, not chasing the story stock.